Rasha Hussein

Rasha Hussein

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CMCecilia Månsson
Cecilia Månsson
PAPaolo Arosio
Paolo Arosio
RHRasha Hussein
Rasha Hussein
HKHarm Kampinga
Harm Kampinga
RHReem M. Hashem
Reem M. Hashem
CECecilia Emanuelsson
Cecilia Emanuelsson
The human molecular chaperone protein DNAJB6 was recently found to inhibit the formation of amyloid fibrils from polyglutamine peptides associated with neurodegenerative disorders such as Huntington disease. We show in the present study that DNAJB6 also inhibits amyloid formation by an even more aggregation-prone peptide (the amyloid-beta peptide, Aβ42, implicated in Alzheimer disease) in a highly efficient manner. By monitoring fibril formation using Thioflavin T fluorescence and far-UV CD spectroscopy, we have found that the aggregation of Aβ42 is retarded by DNAJB6 in a concentration-dependent manner, extending to very low sub-stoichiometric molar ratios of chaperone to peptide. Quantitative kinetic analysis and immunochemistry studies suggest that the high inhibitory efficiency is due to the interactions of the chaperone with aggregated forms of Aβ42 rather than the monomeric form of the peptide. This interaction prevents the growth of such species to longer fibrils and inhibits the formation of new amyloid fibrils through both primary and secondary nucleation. A low dissociation rate of DNAJB6 from Aβ42 aggregates leads to its incorporation into growing fibrils and hence to its gradual depletion from solution with time. When DNAJB6 is eventually depleted, fibril proliferation takes place, but the inhibitory activity can be prolonged by introducing DNAJB6 at regular intervals during the aggregation reaction. These results reveal the highly efficacious mode of action of this molecular chaperone against protein aggregation, and demonstrate that the role of molecular chaperones can involve interactions with multiple aggregated species leading to the inhibition of both principal nucleation pathways through which aggregates are able to form.


1 June 2020 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
RHRasha Hussein
Rasha Hussein
MAMona M. Anwar
Mona M. Anwar
HFHatem S. Farghaly
Hatem S. Farghaly
MKMohamed A. Kandeil
Mohamed A. Kandeil

1 July 2021 in Life Sciences
Verified
Journal Article
Closed access
RHRasha Hussein
Rasha Hussein
DSDoaa M. Sawy
Doaa M. Sawy
MKMohamed A. Kandeil
Mohamed A. Kandeil
HFHatem S. Farghaly
Hatem S. Farghaly

19 February 2019 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
YMYomna S. Mo’men
Yomna S. Mo’men
RHRasha Hussein
Rasha Hussein
MKmohamed kandeil
mohamed kandeil

1 November 2020 in Biotechnology Advances
Verified
Journal Article
Open access
Yasser GaberYasser Gaber
Yasser Gaber
BRBoshra Rashad
Boshra Rashad
RHRasha Hussein
Rasha Hussein
Mai AbdelgawadMai Abdelgawad
Mai Abdelgawad
NANourhan S. Ali
Nourhan S. Ali
AVAnikó Várnai
Anikó Várnai
Lytic polysaccharide monooxygenases (LPMOs) are relatively new enzymes that have been discovered 10 years ago. LPMOs comprise a diverse group of enzymes which play a pivotal role in the depolymerization of sugar-based biopolymers including cellulose, hemicellulose, chitin, and starch. Their mechanism of action relies on the correct coordination of a copper ion in the active site, which is partly composed of the N-terminal histidine. Therefore, correct secretion and folding of these copper-enzymes is fundamental for obtaining a catalytic activity. LPMOs occur in all kingdoms of life; they have been found in viruses, bacteria and eukaryotes, including fungi, plants and animals. In many cases, using homologous expression of these proteins is not feasible and an alternative organism, which can be cultured and is able to heterologously express the protein of interest, is required for studying enzyme properties. Therefore, we made an extensive compilation of expression techniques used for LPMOs the expression and characterization of which have been reported to date. In the current review, we provide a summary of the different techniques, including expression hosts and vectors, secretion methods, and culturing conditions, that have been used for the overexpression and production of this important class of enzymes at laboratory scale. Herein, we compare these techniques and assess their advantages and disadvantages.